CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
Landmark CARTITUDE-4 study results show CARVYKTI® reduced the risk of death by 45 percent after three-year follow-upLate-breaking data featured in an oral presentation at the 21st International Myeloma Society Annual…
AMERICAN REBEL ANNOUNCES 1-FOR-9 REVERSE STOCK SPLIT
Nashville, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) — America’s Patriotic Brand (the “Company”), today announced that it will effect a reverse stock split…
Ledende medarbejderes transaktioner
September 27, 2024 16:51 ET | Source: ORPHAZYME A/S ORPHAZYME A/S Please visit: Our Sponsor
Targa Resources Corp. to Participate in Wolfe Research Utilities, Midstream & Clean Energy Conference
HOUSTON, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that representatives from the Company will participate virtually from Houston, TX in…
Form 8.3 – [ECKOH PLC – 26 09 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology,…
Form 8.3 – [KEYWORDS STUDIOS PLC – 26 09 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Arqit announces leadership transition with the appointment of a new Chief Executive Officer
LONDON, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW), a leading provider of quantum-safe encryption, today announced a leadership transition. Andy Leaver, a seasoned software company…
Peptide Therapeutics Market to Witness 5.94% CAGR by 2031
Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Therapeutics Market will attain the value of USD 68.4 Billion by 2031, with a CAGR of 5.94% during…
Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031
Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of…